News
Although we keep hearing about eVTOL aircraft, barriers such as high prices and regulatory approval may always limit their widespread use. That shouldn't be a problem for the AirKart, though, as it ...
VTOL passenger startup Joby Aviation teams up with L3Harris to develop "defense applications" for its manned and unmanned ...
While the Blade deal makes sense for Joby, as it will help boost its ambitions in the urban air taxi market, the market's reaction seems unjustified and is just the latest evidence that electric ...
Embraer-backed Eve Air Mobility will test Beta Technologies' electric motors on its upcoming eVTOL prototype, while Archer ...
15h
Zacks.com on MSNIs Archer Aviation Stock a Buy, Hold, or Sell Before Q2 Earnings?ACHR's soaring stock price, bold partnerships and Abu Dhabi air taxi launch raise big questions ahead of its earnings report.
AeroTime columnist Gary Vermaak explores the bold claims and real constraints shaping urban air mobility and electric ...
Joby Aviation is advancing toward FAA certification of its electric eVTOL aircraft while acquiring Blade Air Mobility’s ...
Q2 2025 Earnings Call Transcript August 6, 2025 Eve Holding, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.15. Operator: Please stand by. Your program is ...
Archer Aviation has announced two strategic acquisitions aimed at advancing its next-generation defence aircraft development.
Street expects a loss of $0.25 EPS on $0.2 million revenue, with certification progress and defense partnerships under ...
20h
GlobalData on MSNArcher boosts defence capabilities with strategic acquisitionsArcher has made two acquisition to boost its capabilities and help advance the development of its next-generation eVTOL defence aircraft.
aTyr's lead drug, efzofitimod, just completed enrollment in its phase 3 EFZO-FIT trial for pulmonary sarcoidosis, with results expected in 2025's third quarter. Since EFZO-FIT is a single phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results